¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö : 2024-03-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö : 2024-03-16
±³À°ÀÏÀÚ : 2024-03-16
±³À°Àå¼Ò : ¼­¿ï´ëÇб³º´¿ø(¾î¸°À̺´¿ø)CJȦ ÇÏÀ̺긮µå(¿Â-¿ÀÇÁº´Çà)

±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà)_2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ¼­¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¾È°ú

´ã´çÀÚ : ±è¹Ì°æ
¿¬¶ôó : 02-2072-2437

À̸ÞÀÏ : poong1016@snu.ac.kr

±³À°Á¾·ù : ¾È°ú, ±âŸ

Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 60,000¿ø  

ºñ°í Àü¹®ÀÇ 6¸¸¿øÀü°øÀÇ 3¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:00~09:15 In vivo genome editing for IRD in SNUH GEC-GCT ±èÁ¤ÈÆ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:15~09:30 Vision restoration in a Retinitis Pigmentosa mouse model using Artificial Photoreceptor Proteins ÀӸżø(KIST)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:30~09:45 Seoul Artificial Retina Updates ¼­Á¾¸ð(¼­¿ï°ø´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 09:45~10:00 Recent advances in IRD: Era of Whole Genome Analysis ¿À¹é·Ï(Genome Insight)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:00~10:15 Somatic mutation profile in the aged retina and choroid ÁÖ±¤½Ä(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:15~10:30 Perivascular macrophages in the retina-from origin to function ±èÁ¾½Å(Æ÷Ç×°ø´ë)

ÈÞ½Ä 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:30~10:40 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:40~10:55 Optimizing current management of diabetic macular edema ±è¿ë±Ô(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 10:55~11:10 Management of Diabetic retinoapthy: DRCR network update À¯³ª°æ(Áß¾Óº¸Èƺ´¿ø)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:10~11:25 Optimizing current and future treatment of neovascular AMD ±èÀçÈÖ(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:25~11:40 Non-exudative AMD and emerging treatment À±Ã¢±â(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:40~11:55 Updates on pachychoroidal spectrum diseases ¾ÈÁöÀ±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 11:55~12:25 State-of-the-Art Vitrectomy: Head-Up Surgery and Preoperative Evaluation with En Face Imaging Motohiro Kamei(Aichi Medical University)

½Ä»ç 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 12:25~13:25 Group photo & Lunch ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 13:25~13:40 Advances in refractory macular hole management  Áö¿µ¼®(Àü³²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 13:40~13:55 Surgical management of myopic traction maculopathy ¹Ú¿îö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 13:55~14:10 Management of pediatric retinal detachment ±è»óÁø(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:10~14:25 Advances in IOL fixation techniques º¯Àͼö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:25~14:40 Optimizing 3D visualization system in retinal surgery »ç°ø¹Î(¿µ³²ÀÇ´ë)

ÈÞ½Ä 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:40~14:50 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 14:50~15:05 Unveiling retinal disease using nationwide population-based study ¼Û¼öÁ¤(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:05~15:20 Real world practice and burden of retinal diseases based on Common Data Model ¹Ú»óÁØ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:20~15:35 Role of artificial intelligence in retinal imaging and diagnosis Á¶¹üÁÖ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:35~15:50 OCT-based deep learning model for macular degeneration Ȳ´öÁø(Çѱæ¾È°ú)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 15:50~16:05 Explainable AI and updated model in medical image diagnosis ÀÌÇü¿ì(°Ç±¹ÀÇ´ë)

ÈÞ½Ä 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:05~16:15 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:15~16:30 Imaging and pathophysiology of central serous chorioretinopathy ¹éÁö¿ø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:30~16:45 Diagnosis and treatment of autoimmune retinopathy ¿ì¼¼ÁØ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 16:45~17:00 Pentosan polysulfate maculopathy ±è¹Î¼®(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 17:00~17:15 Challenges in the management of intraocular inflammation ¼ÛÁöÈÆ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 03¿ù 16ÀÏ ¼­¿ï´ëº´¿ø CJȦ 17:15~17:30 Advances in intraocular tumor management À̽±Ô(¿¬¼¼ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ¼­¿ï´ëº´¿ø¾È°ú½ÉÆ÷Áö¾ö : 2024-03-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦39ȸ ´ëÇÑ¿Ü°ú´ë»ç¿µ¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦½ÉÆ÷Áö¾ö (2ÀÏÂ÷) : 2024-03-16
´ÙÀ½±Û ´ëÇÑôÃß¿Ü°úÇÐȸ 2024³â Á¦1Â÷ Àü°øÀǸ¦ À§ÇÑ Ã´Ãß ÀÔ¹® ¿¬¼ö°­Á : 2024-03-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 72 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 54 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 44 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 44 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 21 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 43 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷